Blood Reviews
Volume 17, Issue 1 , Pages 33-41 , March 2003

Structural basis of the fibrinogen–fibrin transformation: contributions from X-ray crystallography

  • Russell F Doolittle

      Affiliations

    • Corresponding Author InformationCorrespondence to: Russell F. Doolittle, Center for Molecular Genetics, University of California, San Diego, La Jolla, CA 92093-0634, USA. Tel.: +858-534-4417; Fax: +858-534-4985

References 

  1. Hall CE, Slayter HS. The fibrinogen molecule: its size, shape and mode of polymerization. J. Biophys. Biochem. Cytol. 1959;5:11–17
  2. Bailey K, Astbury WT, Rudall KM. Fibrinogen and fibrin as members of the keratin-myosin group. Nature. 1943;151:716–717
  3. Cohen C. Invited discussion at 1960 symposium on protein structure. J. Polym. Sci. 1961;49:144–145
  4. Bailey K, Bettelheim FR, Lorand L, Middlebrook WR. Action of thrombin in the clottting of fibrinogen. Nature. 1951;167:233–234
  5. Ferry JD. The mechanism of polymerization of fibrin. Proc. Natl. Acad. Sci. USA. 1952;39:566–569
  6. Laudano AL, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc. Natl. Acad. Sci. USA. 1978;75:3085–3089
  7. Chen R, Doolittle RF. γ–γ cross-linking sites in human and bovine fibrin. Biochemistry. 1971;10:4486–4491
  8. McKee PA, Mattock P, Hill RL. Subunit structure of human fibrinogen, soluble fibrin and cross-linked insoluble fibrin. Proc. Natl. Acad. Sci. USA. 1970;66:738–744
  9. Schielen WJG, Voskuilen M, Tesser GI, Nieuwenhuizen W. The sequence Aα-(148–160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 1989;86:8951–8954
  10. Schielen WJG, Adams HPHM, Voskuilen M, Tesser GI, Nieuwenhuizen W. The sequence Aα-(154–159) of fibrinogen is capable of accelerating the t-PA-catalyzed activation of plasminogen. Blood Coagul. Fibrinolysis. 1991;2:465–470
  11. Mosesson MW, Doolittle RF (eds.). Molecular biology of fibrinogen and fibrin. Ann NY Acad Sci 1983; 408
  12. Nieuwenhuizen W, Mosesson MW, De Maat MPM (eds). Fibrinogen. XVIth International Fibrinogen Workshop. Ann NY Acad Sci 2002; vol. 936
  13. Tooney NM, Cohen C. Microcrystals of a modified fibrinogen. Nature. 1972;234:23–25
  14. Rao SPS, Poojary D, Elliott BW, Melanson LA, Oriel B, Cohen C. Fibrinogen structure in projection at 18Å resolution. Electron density by co-ordinated cryo-electron microscopy and X-ray crystallography. J. Mol. Biol. 1991;222:89–98
  15. Everse SJE, Pelletier H, Doolittle RF. Crystallization of fragment D from human fibrinogen. Prot. Sci. 1995;4:1013–1016
  16. Doolittle RF, Everse SJ, Spraggon G. Human fibrinogen: anticipating a three-dimensional structure. FASEB J. 1996;10:1464–1470
  17. Yee VC, Pratt KP, Cote HC, LeTrong I, Chung DW, Davie EW, et al. Crystal structure of a 30kDa C-terminal fragment from the γ chain of human fibrinogen. Structure. 1997;5:125–138
  18. Pratt KP, Cote HCF, Chung DW, Stenkamp RE, Davie EW. The fibrin polymerization pocket: three-dimensional structure of a 30 kDa C-terminal γ chain fragment complexed with Gly-Pro-Arg-Pro. Proc. Natl. Acad. Sci. USA. 1997;94:7176–7181
  19. Hawiger J. Adhesive ends of fibrinogen and its antiadhesive peptides. The end of a saga?. Semin. Hematol. 1995;32:99–101
  20. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its cross-linked counterpart from fibrin. Nature. 1997;389:455–462
  21. Brown JH, Volkmann N, Jun G, Henschen AH, Cohen C. The crystal structure of modified bovine fibrinogen. Proc. Natl. Acad. Sci. USA. 2000;97:85–90
  22. Williams RC. Morphology of bovine fibrinogen monomers and fibrin polymers. J. Mol. Biol. 1981;150:399–408
  23. Yang Z, Mochalkin I, Veerapandian L, Riley M, Doolittle RF. Crystal structure of a native chicken fibrinogen at 5.5Å resolution. Proc. Natl. Acad. Sci. USA. 2000;97:3907–3912
  24. Yang Z, Kollman JM, Pandi L, Doolittle RF. Crystal structure of a native chicken fibrinogen at 2.7Å resolution. Biochemistry. 2001;40:12515–12523
  25. Madrazo J, Brown JH, Litvonowich S, Dominguez R, Yakovlev S, Medved L, et al. Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-Å resolution. Proc. Natl. Acad. Sci. USA. 2001;98:11967–11972
  26. Takagi T, Doolittle RF. Amino acid sequence studies on the α chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site. Biochemistry. 1975;14:5149–5156
  27. Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen Aα-chains. Thromb. Haemost. 1993;69:351–360
  28. Tsurupa G, Latchezar L, Medved L. Structural organization of the fibrin(ogen) αC-domain. Biochemistry. 2002;41:6449–6459
  29. Gorkun OV, Henschen-Edman AH, Ping LF, Lord ST. Analysis of Aα251 fibrinogen: the αC domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X. Biochemistry. 1998;37:15434–15441
  30. Yang Z, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc. Natl. Acad. Sci. USA. 2000;97:14156–14161
  31. Tsurupa G, Medved L. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) αC-domains. Biochemistry. 2001;40:801–808
  32. Koopman J, Haverkate F, Lord ST, Grimbergen J, Mannucci PM. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. J. Clin. Invest. 1992;90:238–244
  33. Gorlatov S, Medved L. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin β chains. Biochemistry. 2002;41:4107–4116
  34. Odrijin TM, Shainoff JR, Lawrence SO, Simpson-Haldaris PJ. Thrombin cleavage enhances exposure of a heparin-binding domain in the N-terminus of the fibrin β chain. Blood. 1996;86:2050–2061
  35. Thompson WD, Smith EB, Stirk CM, Marshall FJ, Stout AJ, Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J. Pathol. 1992;168:47–53
  36. Donahue JP, Patel H, Anderson WF, Hawiger J. Three-dimensional structure of the platelet integrin recognition domain of the fibrinogen γ-chain obtained by carrier protein driven crystallization. Proc. Natl. Acad. Sci. USA. 1994;91:12178–12182
  37. Ware S, Donahue JP, Hawiger J, Anderson WF. Structure of the fibrinogen γ-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization. Prot. Sci. 1999;8:2663–2671
  38. Everse SJ, Spraggon G, Veerapandian L, Doolittle RF. Conformational changes in fragments D double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. Biochemistry. 1999;38:2941–2946
  39. Yokoyama K, Erickson HP, Ikeda Y, Takada Y. Identification of amino acid sequences in fibrinogen γ-chain and tenascin C C-terminal domains critical for binding to integrin αvβ3. J. Biol. Chem. 2000;275:16891–16898
  40. Doolittle RF. A detailed consideration of a principal domain of vertebrate fibrinogen and its relatives. Prot. Sci. 1992;1:1563–1577
  41. Fu Y, Cao Y, Hertzberg KM, Grieninger G. Fibrinogen α genes: conservation of bipartite transcripts and carboxy-terminal-extended α subunits in vertebrates. Genomics. 1995;30:71–76
  42. Spraggon G, Applegate D, Everse SJ, Zhang J-Z, Veerapandian L, Redman C, et al. Crystal structure of a recombinant αEC domain from fibrinogen-420. Proc. Natl. Acad. Sci. USA. 1998;95:9099–9104
  43. Doolittle RF, Spraggon G, Everse SJ. Evolution of vertebrate fibrin formation and the process of its dissolution. In: Plasminogen-Related Growth Factors. CIBA Foundation Symposium. Vol. 212:New York: Wiley; 1997;p. 4–23
  44. Knibbs RN, Osborne SE, Glick GD, Goldstein IJ. Binding determinants of the sialic acid-specific lectin from the slux Limax flavus. J. Biol. Chem. 1993;268:18524–18531
  45. Adema CM, Hertel LA, Miller RD, Loker ES. A family of fibrinogen-related proteins that precipitates parasite-derived molecules is produced by an invertebrate after infection. Proc. Natl. Acad. Sci. USA. 1997;94:8691–8696
  46. Gokudan S, Muta T, Tsuda R, Koori K, Kawahara T, Seki N, et al. Horseshoe crab acetyl group-recognizing lectins involved in innate immunity are structurally related to fibrinogen. Proc. Natl. Acad. Sci. USA. 1999;96:10086–10091
  47. Beisel H-G, Kawabata S-I, Iwanaga S, Huber R, Bode W. Tachylectin-2: crystal structure of a specific GlcNac/GalNac binding lectin. EMBO J. 1999;18:2222–2313
  48. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 1998;37:8637–8642
  49. Morris TA, Marsh JJ, Fagnani R, Hagan M, Moser KM. Degree of polymer orgainzation decreases the binding of a monoclonal antibody raised against the β-chain amino terminus of fibrin. Thromb. Haemost. 1997;77:704–709
  50. Lugovoskoi EV, Komisarenko SV. The use of monoclonal antibodies for studying the fibrin polymerization. Russian J. Bioorg. Chem. 2000;26:883–891
  51. Doolittle RF. Fibrin packing arrangements inferred from crystal structures of fragments D and double-D complexed with synthetic peptide knobs. Jpn. J. Thromb. Hemost. 2000;11:123–130
  52. Yakolev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen binding sites. Biochemistry. 2000;39:15730–15741
  53. Lounes KC, Ping L, Gorkun OV, Lord ST. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and “B–β” interactions have a role in protofibril formation. Biochemistry. 2002;41:5291–5299
  54. Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry. 1980;19:1013–1090
  55. Kuyas C, Doolittle RF. Gly-Pro-Arg-Pro derivatives that bind to human plasma albumin and prevent fibrin formation. Thromb. Res. 1986;43:485–490
  56. Yin YC, Doolittle RF. A latent inhibitor of fibrin polymerization with ancillary anticoagulant activity. Thromb. Res. 2000;97:375–378
  57. Yang Z, Spraggon G, Pandi L, Everse SJ, Riley M, Doolittle RF. Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide. Biochemistry. 2002;41:10213–10224
  58. Everse SJ, Spraggon G, Doolittle RF. A three-dimensional consideration of variant human fibrinogens. Thromb. Haemost. 1998;80:1–9
  59. Cote HC, Lord ST, Pratt KP. γ-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in γ chain of human fibrinogen. Blood. 1998;92:2012–2195
  60. Fellowes AP, Brennan SO, Ridgway H, Heaton DC, George PM. Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (γ280Tyr>Cys): a new variant with defective polymerization. Brit. J. Haematol. 1998;101:24–31
  61. Mullin JL, Brennan SO, Ganly PS, George PM. Fibrinogen Hillsborough: a novel γGly309Asp dysfibrinogen. Haemostas. Thromb. Vasc. Biol. 2002;99:3597–3601
  62. Schweers O, Schonbrunn HE, Marx A, Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence of beta-structure. J. Biol. Chem. 1994;269:24290–24297
  63. Uversky VN, Gillespie JR, Fink AL. Why are “natively unfolded” proteins unstructured under physiological conditions?. Proteins: Struct. Funct. Gen. 2000;41:415–427
  64. Dyson HJ, Wright PE. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 2002;12:54–60

☆ Abbreviations: GPR-, Gly-Pro-Arg-derivatives; GPRPam, Gly-Pro-Arg-Pro-amide; GHRPam, Gly-His-Arg-Pro-amide; t-PA, tissue plasminogen activator.

PII: S0268-960X(02)00060-7

Blood Reviews
Volume 17, Issue 1 , Pages 33-41 , March 2003

Article Tools

* Image Usage & Resolution